Comparative Pharmacology
Head-to-head clinical analysis: NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM LACTATE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM LACTATE IN PLASTIC CONTAINER.
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM LACTATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Normosol-R and Dextrose 5% is a balanced electrolyte solution with dextrose. The dextrose provides caloric support and prevents ketosis. The electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain osmotic balance and acid-base homeostasis. Acetate and gluconate serve as bicarbonate precursors to correct acidosis.
Sodium lactate is converted to bicarbonate in the liver, providing an alkalizing effect to correct metabolic acidosis.
Intravenous infusion; dose depends on fluid and electrolyte needs. Typical adult dose: 500-1000 mL over 1-4 hours, may repeat based on clinical status.
Intravenous (IV) infusion: Initial dose 300-500 mL of 1/6 M (M/6) sodium lactate solution (167 mEq/L of sodium and lactate) infused over 1-2 hours; subsequent doses based on serum bicarbonate levels and clinical response.
None Documented
None Documented
Dextrose: <15 minutes (rapid cellular uptake and metabolism). Electrolytes distribute and are excreted with kinetics dependent on renal function; no plasma half-life defined.
The terminal elimination half-life of lactate is approximately 5–10 minutes due to rapid hepatic metabolism; this short half-life allows quick correction of metabolic acidosis when administered intravenously.
Renal elimination of water and electrolytes; dextrose is metabolized to CO2 and water, with <5% excreted unchanged. Biliary/fecal excretion negligible.
Sodium lactate is metabolized to bicarbonate in the liver via the Cori cycle; less than 5% is excreted unchanged in urine under normal conditions. Biliary/fecal elimination is negligible.
Category C
Category C
Intravenous Fluid/Electrolyte Solution
Electrolyte Solution